Registrations at all UK and ROI sites will be suspended from 17:00 on Thursday 9th April. Randomisation of patients registered for the run-in period by this date can proceed as per guidance found here ...
News
COVID-19 pandemic: Guidance for Add-Aspirin participants
In the current pandemic situation, we know that trial participants may have concerns or questions about taking their trial treatment and attending follow-up appointments. We have provided some general ...
UK Interdisciplinary Breast Cancer Symposium 2020 - Add-Aspirin Survivorship Poster
Click here to view the poster ...
Add-Aspirin Feasibility Data Published
A pre-planned feasibility analysis (based on run-in data from 2253 participants across all tumour cohorts), suggested that aspirin is well-tolerated after radical therapy, with a low burden of toxicit ...
Posting CRFs to the correct address
A reminder to all UK and ROI sites: Please ensure you are posting CRFs to the correct address. MRC CTU has been based at 2nd Floor, 90 High Holborn, London, WC1V 6LJ since October 2017. Post going ...
News and Resources